23andMe CEO and co-founder Anne Wojcicki.. Illustration: Inc; Photo: Getty Images All of 23andMe’s independent directors resigned from its board this week, a rare move that marks the latest ...

The company, which is headed by Sergei Brin’s ex-wife, Anne Wojcicki, has endured a maelstrom of controversy over the past several months, the likes of which has included litigation, layoffs ...

DNA submitted by users to the genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no longer wants a third-party acquisition of the company. The company is ...

But I still remember the first moment I met 23andMe CEO and co-founder Anne Wojcicki in 2007. My editor at the time had set up a meeting between my reporting partner and I and Wojcicki ...

That request epitomises the fall of a company that transformed its chief executive and founder Anne Wojcicki, ex-wife of Google founder Sergey Brin, into a paper billionaire when it floated three ...

23andMe's board resigned over a "distracting difference of view" with cofounder Anne Wojcicki. The board rejected an earlier proposal by Wojcicki to take the company private. Wojcicki told ...

The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki, who wants to take the company private. In a Tuesday letter addressed to Wojcicki, the seven directors ...

'Special Report' anchor Bret Baier provides his perspective and key takeaways from his interview with Vice President Kamala Harris. We Build a Barn, Got Stuck in the MUD and Shot a nice Buck! The MOST ...

CEO Anne Wojcicki has also previously said she'd consider a potential takeover of the company, which has raised concerns among customers about what would happen to their data in the event of a sale.

Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its board resigned en masse Tuesday. The move is almost certainly the final ...

Bloomberg report highlighted that Anne Wojcicki reaffirmed her commitment to privatizing the company. 23andMe witnessed a significant decline in its valuation, once at $6 billion. The board said ...